A drug in which potential tax credits or grants may provide incentives to assist in the research and development for a condition that affects a very small portion of the general population is known as a/an ______________
a. Orphan drug
b. Expedited drug
c. Investigational new drug
d. Phase 1 drug
a
Rationale: a. A company may receive incentives to encourage research and development of a drug that is meant for a small percentage of the general population.
b. An expedited drug is a drug that moves quickly through the normal phases of human testing when that drug may help in the prevention of a public health crisis.
c. A drug gains the status of investigational new drug when it has completed its preclinical testing phase and is ready for human testing.
d. Phase one refers to a drug testing and approval phase.
You might also like to view...
Use of prehospital care reports for quality improvement is an example of their ________ use
A) medical B) administrative C) patient care D) legal
Which of the following contribute to elevated blood pressure in the elderly?I. Increased total peripheral vascular resistanceII. ObesityIII. Sodium intakeIV. Stress ?
A. I, II, III, and IV B. I and III only C. I and II only D. I, II and III only
If a history includes a review of the chief complaint (CC) and a brief history of present illness (HPI) only, it is considered a(n):
A) problem-focused history. B) expanded problem-focused history. C) detailed history. D) comprehensive history.
All of the following are characteristics of absorption bases, EXCEPT
They are non-washable They are difficult to spread They are non-greasy They are anhydrous